Farnesyl pyrophosphate

Biosynthesis of Farnesyl Pyrophosphate

Farnesyl pyrophosphate (FPP) is an important intermediate in the mevalonate pathway, which is crucial for the biosynthesis of terpenes, steroids, and other essential biomolecules. FPP serves as a key building block in the synthesis of cholesterol, coenzyme Q, and dolichol.

Structure and Properties

Farnesyl pyrophosphate is a prenyl compound, consisting of a 15-carbon isoprenoid chain with a pyrophosphate group attached. The molecule is highly reactive due to the presence of the pyrophosphate group, which can participate in various enzymatic reactions.

Biosynthesis

FPP is synthesized from isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP) through a series of enzymatic reactions. The enzyme farnesyl pyrophosphate synthase catalyzes the condensation of one molecule of DMAPP with two molecules of IPP to form FPP. This reaction is a key step in the mevalonate pathway.

Biological Functions

Farnesyl pyrophosphate plays a critical role in several biological processes:

• Cholesterol Biosynthesis: FPP is a precursor in the synthesis of squalene, which is subsequently converted into cholesterol.
• Protein Prenylation: FPP is used in the post-translational modification of proteins, such as the farnesylation of Ras proteins, which is essential for their proper localization and function.
• Synthesis of Other Isoprenoids: FPP is a precursor for the synthesis of various isoprenoids, including ubiquinone (coenzyme Q) and dolichol.

Clinical Significance

Inhibitors of farnesyl pyrophosphate synthase, such as bisphosphonates, are used in the treatment of diseases like osteoporosis and Paget's disease. These inhibitors prevent the synthesis of FPP, thereby affecting the prenylation of proteins involved in bone resorption.

Related Pages

• Mevalonate pathway
• Isoprenoid
• Cholesterol
• Protein prenylation